Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,595
Closed -$273K 94
2025
Q4
$273K Buy
+2,595
New +$244K 0.24% 82
2023
Q3
$288K Hold
2,802
0.5% 52
2023
Q2
$323K Hold
2,802
0.51% 45
2023
Q1
$298K Hold
2,802
0.49% 50
2022
Q4
$311K Sell
2,802
-278
-9% -$28.4K 0.48% 52
2022
Q3
$267K Hold
3,080
0.38% 48
2022
Q2
$281K Hold
3,080
0.39% 54
2022
Q1
$253K Hold
3,080
0.28% 61
2021
Q4
$236K Sell
3,080
-1
-0% -$80 0.25% 66
2021
Q3
$231K Hold
3,081
0.25% 63
2021
Q2
$240K Sell
3,081
-148
-5% -$11K 0.25% 65
2021
Q1
$238K Hold
3,229
0.26% 55
2020
Q4
$252K Hold
3,229
0.28% 54
2020
Q3
$256K Hold
3,229
0.33% 50
2020
Q2
$238K Sell
3,229
-14
-0.4% -$1.05K 0.33% 49
2020
Q1
$250K Hold
3,243
0.36% 50
2019
Q4
$268K Buy
+3,243
New +$266K 0.33% 66

Other funds holding MRK

QP Wealth Management's MRK Position: Q1 2026 in Review

QP Wealth Management sold out of Merck (MRK) in Q1 2026, closing a stake of 2,595 shares — an estimated $273K sold.

QP Wealth Management first reported a position in MRK in Q4 2019 and held it in 17 quarters. The position peaked at $323K in Q2 2023. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • QP Wealth Management reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
  • QP Wealth Management sold 2,595 Merck shares in Q1 2026, an estimated $273K.
  • QP Wealth Management first reported a position in Merck in Q4 2019 and held it in 17 quarters.
  • QP Wealth Management's Merck position peaked at $323K in Q2 2023.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on QP Wealth Management's 13F filing for Q1 2026, filed 22 Apr 2026.